Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays
Joanna Budna(Poznan University of Medical Sciences), Catherine Alix‐Panabières(Université de Montpellier), Monika Świerczewska(Poznan University of Medical Sciences), Agnieszka Jankowiak(Poznan University of Medical Sciences), D. Azria(Inserm), Klaus Pantel(Universität Hamburg), Andrzej Antczak(Poznan University of Medical Sciences), Wojciech A. Cieślikowski(Poznan University of Medical Sciences), M. Zabel(Poznan University of Medical Sciences), Martine Mazel(Université de Montpellier), Michał Nowicki(Poznan University of Medical Sciences), Agnieszka Ida(Poznan University of Medical Sciences)
Cited by 32
Related Papers
Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer
|Journal of Clinical Oncology|2012|431
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
|British Journal of Cancer|2020|402
Hemodynamic Forces Tune the Arrest, Adhesion, and Extravasation of Circulating Tumor Cells
|Developmental Cell|2018|328